Literature DB >> 34413937

The Potential of c-KIT Kinase inhibitors in Cancer Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2021        PMID： 34413937      PMCID： PMC8365623          DOI： 10.1021/acsmedchemlett.1c00332

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

1.  Rational Drug Design Approach of Receptor Tyrosine Kinase Type III Inhibitors.

Authors:  Cheolhee Kim; Eunae Kim
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 2.  Gastrointestinal stromal tumour.

Authors:  Heikki Joensuu; Peter Hohenberger; Christopher L Corless
Journal:  Lancet       Date:  2013-04-24       Impact factor: 79.321

Review 3.  The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.

Authors:  Henrique J Cardoso; Marília I Figueira; Sara Correia; Cátia V Vaz; Sílvia Socorro
Journal:  Mol Reprod Dev       Date:  2014-10-30       Impact factor: 2.609

Review 4.  New targets and therapies for gastrointestinal stromal tumors.

Authors:  Agnieszka Wozniak; Yemarshet K Gebreyohannes; Maria Debiec-Rychter; Patrick Schöffski
Journal:  Expert Rev Anticancer Ther       Date:  2017-12       Impact factor: 4.512
  4 in total
  1 in total

1.  Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis.

Authors:  Prashant J Chaudhari; Sanjaykumar B Bari; Sanjay J Surana; Atul A Shirkhedkar; Chandrakant G Bonde; Saurabh C Khadse; Vinod G Ugale; Akhil A Nagar; Rameshwar S Cheke
Journal:  ACS Omega       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.